Evaxion Biotech A/S Stock Forecast, Price & News

Evaxion Biotech A/S (NASDAQ:EVAX) Frequently Asked Questions

Is Evaxion Biotech A/S a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Evaxion Biotech A/S in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Evaxion Biotech A/S stock.
View analyst ratings for Evaxion Biotech A/S or view top-rated stocks.

Are investors shorting Evaxion Biotech A/S?

Evaxion Biotech A/S saw a increase in short interest in May. As of May 3rd, there was short interest totaling 0 shares, an increase of NaN from the April 18th total of 0 shares. Based on an average daily volume of 23,692 shares, the days-to-cover ratio is presently 0.0 days.
View Evaxion Biotech A/S's Short Interest.

When is Evaxion Biotech A/S's next earnings date?

Evaxion Biotech A/S is scheduled to release its next quarterly earnings announcement on Wednesday, May 11th 2022.
View our earnings forecast for Evaxion Biotech A/S.

How can I listen to Evaxion Biotech A/S's earnings call?

Evaxion Biotech A/S will be holding an earnings conference call on Wednesday, May 11th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Evaxion Biotech A/S's earnings last quarter?

Evaxion Biotech A/S (NASDAQ:EVAX) announced its quarterly earnings data on Tuesday, March, 22nd. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.09.
View Evaxion Biotech A/S's earnings history.

What price target have analysts set for EVAX?

2 brokers have issued 12 month price objectives for Evaxion Biotech A/S's shares. Their forecasts range from $21.00 to $23.00. On average, they expect Evaxion Biotech A/S's stock price to reach $22.00 in the next year. This suggests a possible upside of 688.5% from the stock's current price.
View analysts' price targets for Evaxion Biotech A/S or view top-rated stocks among Wall Street analysts.

Who are Evaxion Biotech A/S's key executives?

Evaxion Biotech A/S's management team includes the following people:

• Dr. Lars Aage-Staal Wegner M.D., Chief Exec. Officer (Age 47, Pay $942k)
• Dr. Niels Iversen Moeller M.D., Co-Founder & VP of Bus. (Age 43, Pay $213k)
• Mr. Andreas Holm Mattsson, Co-Founder & Chief Innovation Officer (Age 46, Pay $213k)
• Mr. Bo Lokke Karmark, Chief Financial Officer (Age 57)
• Mr. Jesper Nyegaard Nissen, COO & Interim CFO (Age 52)
• Dr. Birgitte Rono Ph.D., Chief Scientific Officer (Age 46)
• Dr. Jürgen Langhärig EMBA, Ph.D., Head of Bus. Devel. & Member of Advisory Board
• Dr. Erik Deichmann Heegaard DMSC, M.D., Ph.D., Chief Medical Officer (Age 54)

Who are some of Evaxion Biotech A/S's key competitors?

Some companies that are related to Evaxion Biotech A/S include Graphite Bio (GRPH), Social Capital Suvretta Holdings Corp. III (DNAC), Scholar Rock (SRRK), Dynamics Special Purpose (DYNS), Eiger BioPharmaceuticals (EIGR), Molecular Partners (MOLN), Fusion Pharmaceuticals (FUSN), Innate Pharma (IPHA), Checkmate Pharmaceuticals (CMPI), Lineage Cell Therapeutics (LCTX), Gritstone bio (GRTS), Poseida Therapeutics (PSTX), Oyster Point Pharma (OYST), Cellectis (CLLS) and Genfit (GNFT).
View all of EVAX's competitors.

When did Evaxion Biotech A/S IPO?

(EVAX) raised $31 million in an IPO on Friday, February 5th 2021. The company issued 2,800,000 shares at $10.00-$12.00 per share. Oppenheimer & Co. acted as the underwriter for the IPO and Ladenburg Thalmann was co-manager.

What is Evaxion Biotech A/S's stock symbol?

Evaxion Biotech A/S trades on the NASDAQ under the ticker symbol "EVAX."

How do I buy shares of Evaxion Biotech A/S?

Shares of EVAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evaxion Biotech A/S's stock price today?

One share of EVAX stock can currently be purchased for approximately $2.79.

How much money does Evaxion Biotech A/S make?

Evaxion Biotech A/S has a market capitalization of $64.73 million. The company earns $-24.53 million in net income (profit) each year or ($1.25) on an earnings per share basis.

How many employees does Evaxion Biotech A/S have?

Evaxion Biotech A/S employs 61 workers across the globe.

What is Evaxion Biotech A/S's official website?

The official website for Evaxion Biotech A/S is www.evaxion-biotech.com.

Where are Evaxion Biotech A/S's headquarters?

Evaxion Biotech A/S is headquartered at BREDGADE 34E, COPENHAGEN K G7, 1260.

How can I contact Evaxion Biotech A/S?

Evaxion Biotech A/S's mailing address is BREDGADE 34E, COPENHAGEN K G7, 1260. The company can be reached via phone at 45-5353-1850 or via email at [email protected].